Prevalence and pathogenesis of aortic valve calcifications;Prävalenz und pathogenese von aortenklappenkalzifikationen

Herz

Volumn 31, Issue 7, 2006, Pages 629-634

  Koos, Ralf ^a   Brandenburg, Vincent ^a   Ketteler, Markus ^a   Kühl, Harald Peter ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Aortic valve; Calcification; Pathogenesis; Prevalence

Indexed keywords

PHENPROCOUMON;

AORTA VALVE STENOSIS; CALCIFICATION; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; HUMAN; PATHOGENESIS; PREVALENCE; RADIODIAGNOSIS; REVIEW;

ADULT; AGE FACTORS; AGED; ALPHA-FETOPROTEINS; ANIMALS; AORTIC VALVE; CALCINOSIS; CALCIUM CHANNEL BLOCKERS; CONTROLLED CLINICAL TRIALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; HEART VALVE DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PREVALENCE; RISK FACTORS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 33750540194     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2874-y     Document Type: Review

References (49)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630-4.
2. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005;111:920-5.
3. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7.
4. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 1991;12:10-4.
5. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989;13:545-50.
6. Oh JK, Taliercio CP, Holmes DR Jr, et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients. J Am Coll Cardiol 1988;11:1949-84.
7. Sutton-Tyrell K, Kuller LH, Edmundowicz D, et al. Usefulness of electron beam tomography to detect progression of coronary and aortic calcium in middle-aged women. Am J Cardiol 2001;87:560-5.
8. Ohnesorge B, Flohr T, Fischbach R, et al. Reproducibility of coronary calcium quantification in repeat examinations with retrospectively ECG-gated multisection spiral CT. Eur Radiol 2002;12:1532-40.
9. Shavelle DM, Takasu J, Budoff MJ, et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359:1125-6.
10. Morghan-Hughes GJ, Owens PE, Roobottom CA, et al. Three dimensional volume quantification of aortic valve calcification using multislice computed tomography. Heart 2003;89:1191-4.
11. Koos R, Mahnken AH, Sinha AM, et al. Aortic valve calcification as a marker for aortic stenosis severity: assessment on 16-MDCT. AJR Am J Roentgenol 2004;183:1813-8.
12. Feuchtner GM, Dichte W, Friedrich GJ, et al. Multisclice computed tomography for detection of patients with aortic valve stenosis and quantification of severity. J Am Coll Cardiol 2006;47:1410-7.
13. Woodring JH, West JW. CT of aortic and mitral valve calcification. J Ky Med Assoc 1989;87:177-80.
14. Lippert JA, White CS, Mason AC, et al. Calcification of aortic valve detected incidentally on CT scans: prevalence and clinical significance. AJR Am J Roentgenol 1995;164:73-7.
15. Hunold P, Schmermund A, Seibel RM, et al. Prevalence and clinical significance of accidental findings in electron-beam tomographic scans for coronary artery calcification. Eur Heart J 2001;22:1748-58.
16. Liu F, Coursey CA, Graham-Clarke C, et al. Aortic valve calcification as an incidental finding at CT of the elderly: severity and location as predictors of aortic stenosis. AJR Am J Roentgenol 2006;186:342-9.
17. Koos R, Kühl HP, Mühlenbruch G, et al. Prevalence and clinical significance of aortic valve calcification detected incidentally on CT scans: comparison with echocardiography. Radiology 2006: in press (Epub 2006 Aug 14)..
18. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7.
19. Batson GA, Urquhart W, Sideris DA. Radiological features in aortic stenosis. Clin Radiol 1972;23:140-4.
20. Green CE, Kelly MJ. A renewed role for fluoroscopy in the evaluation of cardiac disease. Radiol Clin North Am 1980;18:345-57.
21. Schwarten DE. Radiologic examination of the heart. Cardiovasc Clin 1981;12:75-93.
22. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006;47:1027-34.
23. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to bedside-emerging clinical and cellular concepts. Heart 2003;89:801-5.
24. Freeman RV, Crittenden G, Otto C. Acquired aortic stenosis. Expert Rev Cardiovasc Ther 2004;2:107-16.
25. Palta S. New insights into the progression of aortic stenosis. Circulation 2000;101:2497-502.
26. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-8.
27. Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 2003;108:1804-8.
28. Ortlepp JR, Pillich M, Schmitz F, et al. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe aortic stenosis. J Heart Valve Dis 2006;15:502-8.
29. Olsson M, Rosenqvist M, Nilsson J. Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol 1994;24:1664-71.
30. Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T lymphocytes and expression of interleukin-2-receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-70.
31. O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis. ArteriosclerThromb Vasc Biol 1996;16:523-32.
32. Mohler ER III, Adam LP, McClelland P, et al. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997;17:547-52.
33. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
34. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-30.
35. Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003;14:159-68.
36. Fox CS, Larson MG, Vansan RS, et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham Heart Study. J Am Soc Nephrol 2006;17:521-7.
37. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004;95:560-7.
38. Ketteler M, Wanner C, Metzger T, et al. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 2003;84:S84-7.
39. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
40. Schurgers LJ, Teunissen KJ, Knapen MH, et al. Novel confirmation-specific antibodies against matrix gamma-carboxylated acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005;25:1629-33.
41. Koos R, Mahnken AH, Muhlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005;96:747-9.
42. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100-5.
43. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
44. 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979;64:1118-29.
45. Brandenburg VM, Westenfeld R, Martin D, et al. Effect of calcimimetics on mineral metabolism in fetuin-A deficient mice. J Am Soc Nephrol 2005;16:749A.
46. Wang AYM, Woo J, Lam WKC, et al. Associations of serum fetuin-A with malnutrition, inflammation atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005;20:1676-85.
47. Wang AY, Woo J, Wang M, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-36.
48. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005;67:2295-304.
49. Koos R, Kuehl HP, Mahnken AH, et al. Association of low fetuin-A concentrations and inflammation with the severity of aortic valve calcification. J Am Coll Cardiol 2006;47:287A.